These findings strongly suggest that HBV-induced upregulation of METTL14 in normal liver cells promotes m6A modification of Foxp4 mRNA, leading to increased RNA stability and potentially contributing to the development of HCC. The gene discussed is FOXP4; the disease is hepatocellular carcinoma.